GA

GALAPAGOS NV

  • CIK: 0001421876
  • EIN: 00-0000000
  • Business address: GEN DE WITTELAAN L11 A3, 2800 MECHELEN, Belgium, 00000

Information

  • Mailing address
    GEN DE WITTELAAN L11 A3, 2800 MECHELEN, C9, 00000
  • Phone
    3215342900
  • State location
    Belgium
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About GALAPAGOS NV

GALAPAGOS NV (CIK: 0001421876) is an American company incorporated in the state of Belgium. Head office is located at GEN DE WITTELAAN L11 A3, 2800 MECHELEN, Belgium, 00000. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. GALAPAGOS NV is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by GALAPAGOS NV

Filings Format Description Filed/Effective File/Film Number
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001104659-24-107055 (34 Act) Size: KB		 Oct-08-2024

005-88880

241360697
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-005528 (34 Act) Size: KB		 Oct-07-2024

001-37384

241356025
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-005412 (34 Act) Size: KB		 Sep-30-2024

001-37384

241339931
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-005215 (34 Act) Size: KB		 Sep-16-2024

001-37384

241301488
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-005034 (34 Act) Size: KB		 Sep-03-2024

001-37384

241275066
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-004917 (34 Act) Size: KB		 Aug-23-2024

001-37384

241236419
SC 13D Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001104659-24-092414 (34 Act) Size: KB		 Aug-23-2024

005-88880

241236218
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-004881 (34 Act) Size: KB		 Aug-21-2024

001-37384

241228829
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-24-192845 (34 Act) Size: KB		 Aug-02-2024

001-37384

241170856
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-003460 (34 Act) Size: KB		 Jun-17-2024

001-37384

241046963
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-003174 (34 Act) Size: KB		 May-30-2024

001-37384

241006175
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-002936 (34 Act) Size: KB		 May-16-2024

001-37384

24956023
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-002929 (34 Act) Size: KB		 May-16-2024

001-37384

24953622
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-002516 (34 Act) Size: KB		 May-03-2024

001-37384

24911060
SC 13D/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0001193125-24-129680 (34 Act) Size: KB		 May-02-2024

005-88880

24910548
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-24-127621 (34 Act) Size: KB		 May-01-2024

001-37384

24904040
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-002375 (34 Act) Size: KB		 May-01-2024

001-37384

24899220
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001896 (34 Act) Size: KB		 Apr-08-2024

001-37384

24828334
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-24-082153 (34 Act) Size: KB		 Mar-29-2024

001-37384

24804692
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001709 (34 Act) Size: KB		 Mar-29-2024

001-37384

24801920

Recent 20 filings. View all GALAPAGOS NV filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • GALAPAGOS NV overview
  • GALAPAGOS NV job
  • GALAPAGOS NV stock
  • GALAPAGOS NV ownership
  • GALAPAGOS NV CEO
  • GALAPAGOS NV documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3226 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3346 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2115 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4866 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1087 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1900 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1855 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2777 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4428 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by